Kramer Holly, Han Cong, Post Wendy, Goff David, Diez-Roux Ana, Cooper Richard, Jinagouda Sujata, Shea Steven
Department of Preventive Medicine, Loyola University, Chicago, Illinois, USA.
Am J Hypertens. 2004 Oct;17(10):963-70. doi: 10.1016/j.amjhyper.2004.06.001.
Most previous studies investigating the association between ethnicity and hypertension focused on differences between African Americans and whites and did not include other racial/ethnic groups such as Chinese or Hispanics.
We used data from the Multi-Ethnic Study of Atherosclerosis (MESA), a population-based study of 6814 adults without clinical cardiovascular disease, to examine the association between ethnicity and hypertension and hypertension treatment among white, African American, Chinese, and Hispanic ethnic groups.
The prevalence of hypertension, defined as systolic blood pressure (BP) <140 mm Hg and diastolic BP <90 mm Hg or self-reported treatment for hypertension, was significantly higher in African Americans compared to whites (60% v 38%; P < .0001), whereas prevalence in Hispanic (42%) and Chinese participants (39%) did not differ significantly from that in whites. After adjustment for age, body mass index, prevalence of diabetes mellitus, and smoking, African American (odds ratio [OR] 2.21; 95% confidence interval [95% CI] 1.91-2.56) and Chinese (OR 1.30; 95% CI 1.07-1.56) ethnicity were significantly associated with hypertension compared to whites. Among hypertensive MESA participants, the percentage of treated but uncontrolled hypertension in whites (24%) was significantly lower than in African Americans (35%, P < .0001), Chinese (33%, P = .003), and Hispanics (32%, P = .0005), but only African-American race/ethnicity remained significantly associated with treated but uncontrolled hypertension after controlling for socioeconomic factors (OR 1.35; 95% CI 1.07-1.71). Diuretic use was lowest in the Chinese (22%) and Hispanic participants (32%) and was significantly lower in these groups compared with white participants (47%; P < .0001 for both comparisons).
Programs to improve hypertension treatment and control should focus on a better understanding of differences in the prevalence of hypertension and hypertension control among minority groups in the United States, especially African Americans, compared with whites, and on techniques to prevent hypertension and improve control in high-risk groups.
以往大多数研究种族与高血压之间关联的研究都集中在非裔美国人和白人之间的差异上,未纳入其他种族/族裔群体,如华裔或西班牙裔。
我们使用了动脉粥样硬化多族裔研究(MESA)的数据,这是一项针对6814名无临床心血管疾病成年人的基于人群的研究,以检验白人、非裔美国人、华裔和西班牙裔族裔群体中种族与高血压及高血压治疗之间的关联。
高血压的患病率定义为收缩压(BP)<140 mmHg且舒张压BP <90 mmHg或自我报告的高血压治疗情况,与白人相比,非裔美国人的患病率显著更高(60%对38%;P <.0001),而西班牙裔(42%)和华裔参与者(39%)的患病率与白人相比无显著差异。在调整年龄、体重指数、糖尿病患病率和吸烟因素后,与白人相比,非裔美国人(优势比[OR] 2.21;95%置信区间[95% CI] 1.91 - 2.56)和华裔(OR 1.30;95% CI 1.07 - 1.56)种族与高血压显著相关。在患有高血压的MESA参与者中,白人中接受治疗但未得到控制的高血压患者百分比(24%)显著低于非裔美国人(35%,P <.0001)、华裔(33%,P =.003)和西班牙裔(32%,P =.0005),但在控制社会经济因素后,只有非裔美国人种族/族裔与接受治疗但未得到控制的高血压仍显著相关(OR 1.35;95% CI 1.07 - 1.71)。华裔(22%)和西班牙裔参与者(32%)的利尿剂使用率最低,与白人参与者(47%)相比,这些群体的使用率显著更低(两项比较P均<.0001)。
改善高血压治疗和控制的项目应着重更好地理解美国少数族裔群体(尤其是非裔美国人)与白人相比在高血压患病率和高血压控制方面的差异,以及预防高血压和改善高危群体控制情况的技术。